Rapid Microbiology Methods Submissions Reviewed By Special FDA Team
This article was originally published in The Pink Sheet Daily
Executive Summary
The agency’s four-person rapid microbiology methods review and inspection team was formed under the process analytical technology initiative. FDA is “very enthusiastic” about methods that allow for faster microbial testing.
You may also be interested in...
FDA Moving Toward PAT Standardized Nomenclature And Definitions
The process analytical technology component of FDA's drug quality initiative will be assisted by an independent standards-making effort and agency encouragement of comparability protocols. Part 11 and dispute resolution are other quality initiative components drawing industry input.
Merck Tax Settlement Could Be Smaller Than GSK’s $3.4 Bil. IRS Deal
A possible settlement between Merck and tax authorities could be significantly smaller than GlaxoSmithKline's recent settlement with the IRS based on the companies' projected liability
McKindler? New Pfizer CEO Echoes McKinnell’s Views On Payers, Scale
Pfizer's success will depend on its ability to negotiate the paradox of increasing demand for pharmaceuticals coupled with growing attempts to restrain costs, CEO Jeffrey Kindler said